1
Country: USA | Funding: $555.6M
CG Oncology is developing the next evolution of oncolytic immunotherapy for patients with advanced cancers.
CG Oncology is developing the next evolution of oncolytic immunotherapy for patients with advanced cancers.
2
Country: USA | Funding: $209M
Ikena Oncology is a biotechnology company that advances new immunometabolic therapies for cancer.
Ikena Oncology is a biotechnology company that advances new immunometabolic therapies for cancer.
3
Country: USA | Funding: $205M
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
4
Country: USA | Funding: $112.3M
iMDx is focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
iMDx is focused on cancers with large patient populations and significant unmet need. The company is developing three genetic tests – blood tests for breast cancer and lung cancer, and a urine-based test for bladder cancer.
5
Country: USA | Funding: $106M
Totus Medicines is a provider of chemical biology technologies by creating life-changing covalent drugs.
Totus Medicines is a provider of chemical biology technologies by creating life-changing covalent drugs.
6
Country: France | Funding: €4.7M
VitaDX is developing a non-invasive medical device for early detection of bladder cancer, based on a syndicate of French academic research.
VitaDX is developing a non-invasive medical device for early detection of bladder cancer, based on a syndicate of French academic research.
7
Country: USA | Funding: $2M
Liquid Biotech is a technology for cancer diagnostics and gene discover
Liquid Biotech is a technology for cancer diagnostics and gene discover
